Fig. 5From: Plasma ceramides as biomarkers for microvascular disease and clinical outcomes in diabetes and myocardial infarctionRoc curve analyses of three reference ceramide ratios (C 18.0/16.0; C 18.0/24.0 & C 18.0/24.1) Versus 11-ceramide panelBack to article page